MannKind Corp. (MNKD)

[Hypi]

UTHR CEO today at Oppenheimer's conference talking about his product pipeline. As we all know UTHR is a $5B market cap company and partnering with MNKD for other drugs.

The CEO just spoke about their Hypertension drug and how MNKD's technosphere device will replace all nebulizers currently in use with this drug. Stated 100% replacement with technosphere. This is a huge development and validates the technology for other compounds as well.

Worth listening to the presentation as its only 1/2 hour and the last 10 minutes are key. You can go to UTHR's website and investors relation page to get a playback.

They still owe us $45 million and royalties could be over $100M a year once it gets out in the market.

I still feel MNKD can easily do $100 million in revenue this year and I've stated why in my previous posts. The sky is the limit and these prices aren't going to last much longer. I still think double digits by years end.